Intracellular bacterial communities of uropathogenic Escherichia coli in urinary tract pathogenesis

Trends in Microbiology
Gregory G AndersonScott J Hultgren

Abstract

Urinary tract infections in young, healthy women frequently recur, despite their traditional classification as acute infections. Conventional wisdom dictates that uropathogens causing recurrent infections in such individuals come from the fecal or vaginal flora, in the same manner as the initial infection. However, recent studies of uropathogenic Escherichia coli have found that it can carry out a complex developmental program within the superficial epithelial cells of the mouse bladder, forming intracellular bacterial communities with many biofilm-like properties. These intracellular biofilms allow the bacteria to outlast a strong host immune response to establish a dormant reservoir of pathogens inside the bladder cells. Re-emergence of bacteria from this reservoir might be the source of recurrent infection.

Citations

Sep 8, 2012·Future Microbiology·Thien-Fah Mah
Aug 9, 2006·Proceedings of the National Academy of Sciences of the United States of America·Jaione ValleJean-Marc Ghigo
Sep 2, 2005·Proceedings of the National Academy of Sciences of the United States of America·Makoto KurodaToshiko Ohta
May 31, 2014·BioMed Research International·Gilho LeeDaša Zupančič
Jul 23, 2014·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Xiao-fei ShenNing Huang
Nov 15, 2014·Glycoconjugate Journal·Iwona Kątnik-PrastowskaAgata Matejuk
Apr 16, 2005·Clinical Microbiology Reviews·Alain L Servin
Aug 1, 2007·Antimicrobial Agents and Chemotherapy·S V LynchA Matin
Nov 30, 2007·PLoS Biology·HoJung ChoAndre Levchenko
Jan 19, 2008·Clinical Microbiology Reviews·S M JacobsenM E Shirtliff
Mar 19, 2008·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Huaibin WangXiang-Peng Kong
Oct 3, 2009·Infection and Immunity·Tracy F NicholsonDavid A Hunstad
Dec 19, 2009·Proceedings of the National Academy of Sciences of the United States of America·Swaine L ChenScott J Hultgren
Apr 9, 2010·The Journal of Biological Chemistry·Anil K OjhaGraham F Hatfull
Oct 25, 2011·BMC Pediatrics·Ruth B ThorntonPeter C Richmond
Jan 9, 2013·Transactions of the Royal Society of Tropical Medicine and Hygiene·Jyotsna AgarwalRicha Srivastava
Sep 26, 2013·Mucosal Immunology·M A Ingersoll, M L Albert
Aug 24, 2006·Molecular Microbiology·Marco R OggioniGianni Pozzi
Aug 6, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Luciana RobinoRafael Vignoli
Jul 1, 2014·Molecular Physics·Courtney Reichhardt, Lynette Cegelski
Aug 21, 2015·PLoS Pathogens·Surabhi KhandigeJakob Møller-Jensen
Jul 17, 2015·PLoS Pathogens·Gabriela Mora-BauMolly A Ingersoll
Jun 25, 2016·Antibiotics·Tianyan SongSun Nyunt Wai
Oct 19, 2016·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Shu-Cheng LiuZi-Li Pang
May 14, 2016·American Journal of Physiology. Renal Physiology·J Todd Purves, F Monty Hughes
Mar 21, 2018·International Urogynecology Journal·Sheela SwamyJames Malone-Lee
Aug 8, 2018·Journal of Veterinary Internal Medicine·Zachary T KernSara K Lyle
Mar 11, 2010·Letters in Applied Microbiology·M WainwrightK Meegan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
Sheryl S JusticeScott J Hultgren
Proceedings of the National Academy of Sciences of the United States of America
Indira U Mysorekar, Scott J Hultgren
Antimicrobial Agents and Chemotherapy
Matthew G Blango, Matthew A Mulvey
© 2021 Meta ULC. All rights reserved